These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 5289422)

  • 1. L-asparaginase induced alteration of amethopterin (methotrexate) activity in mouse leukemia L5178Y.
    Capizzi RL; Summers WP; Bertino JR
    Ann N Y Acad Sci; 1971 Nov; 186():302-11. PubMed ID: 5289422
    [No Abstract]   [Full Text] [Related]  

  • 2. L-asparaginase-induced modulation of methotrexate polyglutamylation in murine leukemia L5178Y.
    Sur P; Fernandes DJ; Kute TE; Capizzi RL
    Cancer Res; 1987 Mar; 47(5):1313-8. PubMed ID: 2434214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth rate and cell kill.
    Hryniuk WM; Bertino JR
    Ann N Y Acad Sci; 1971 Nov; 186():330-42. PubMed ID: 5289425
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of methotrexate cytotoxicity by asparaginase inhibition of methotrexate polyglutamate formation.
    Jolivet J; Cole DE; Holcenberg JS; Poplack DG
    Cancer Res; 1985 Jan; 45(1):217-20. PubMed ID: 2578094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of l-asparaginase and asparagine deprivation on RNA metabolism in mouse leukemia L 5178Y cells in suspension culture.
    Nakashima T; Kuwano M; Akiyama S; Endo H
    Cancer Res; 1976 Oct; 36(10):3616-21. PubMed ID: 986238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of synthesis of protein and nucleic acid in mouse and human leukemia cells by L-asparaginase in vitro].
    Benvenisty DS
    Harefuah; 1972 Jan; 82(2):68-70. PubMed ID: 4673650
    [No Abstract]   [Full Text] [Related]  

  • 7. Schedule-dependent therapeutic synergism for L-asparaginase and methotrexate in leukemic (L5178Y) mice.
    Vadlamudi S; Krishna B; Reddy VV; Goldin A
    Cancer Res; 1973 Sep; 33(9):2014-9. PubMed ID: 4725366
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential cell permeability and the basis for selective activity of methotrexate during therapy of the L1210 leukemia.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1973 Jun; 33(6):1290-4. PubMed ID: 4718678
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in the deoxyribonucleoside triphosphate pools of mouse 5178Y lymphoma cells following exposure to methotrexate or 5-fluorouracil.
    Tattersall MH; Harrap KR
    Cancer Res; 1973 Dec; 33(12):3086-90. PubMed ID: 4543390
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of in vivo treatment with L-asparaginase on the in vitro uptake and phosphorylation of some antileukemic agents.
    Nahas A; Capizzi RL
    Cancer Res; 1974 Oct; 34(10):2689-93. PubMed ID: 4413062
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of amino acid depletion in combined treatment of neoplastic cells with methotrexate and L-asparaginase.
    Chlopkiewicz B; Koziorowska J
    Cancer Res; 1975 Jun; 35(6):1524-9. PubMed ID: 805660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of the antiproliferative action of 1- -D-arabinofuranosylcytosine by methotrexate in murine leukemic cells (L5178Y).
    Hoovis ML; Chu MY
    Cancer Res; 1973 Mar; 33(3):521-5. PubMed ID: 4734734
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction and characteristics of resistance to L-asparaginase (NSC-109229) in mouse leukemia L5178Y.
    Schmid FA; Hutchison DJ
    Cancer Chemother Rep; 1971 Apr; 55(2):115-21. PubMed ID: 5118682
    [No Abstract]   [Full Text] [Related]  

  • 14. Relative toxicity of methotrexate in several tissues of mice bearing Lewis lung carcinoma.
    Zaharko DS; Dedrick RL; Peale AL; Drake JC; Lutz RJ
    J Pharmacol Exp Ther; 1974 Jun; 189(3):585-92. PubMed ID: 4843162
    [No Abstract]   [Full Text] [Related]  

  • 15. The mechanism of action of methotrexate. II. Augmentation by vincristine of inhibition of deoxyribonucleic aic synthesis by methotrexate in Ehrlich ascites tumor cells.
    Goldman ID; Fyfe MJ
    Mol Pharmacol; 1974 Mar; 10(2):275-82. PubMed ID: 4859543
    [No Abstract]   [Full Text] [Related]  

  • 16. The mechanism of action of methotrexate in cultured L5178Y leukemia cells.
    Hryniuk WM
    Cancer Res; 1975 Apr; 35(4):1085-92. PubMed ID: 1054288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the poor correlation between the inhibition by methotrexate of dihydrofolate reductase and of deoxynucleoside incorporation into DNA.
    Roberts D; Wodinsky I
    Cancer Res; 1968 Oct; 28(10):1955-62. PubMed ID: 5696929
    [No Abstract]   [Full Text] [Related]  

  • 18. Purineless death as a link between growth rate and cytotoxicity by methotrexate.
    Hryniuk WM
    Cancer Res; 1972 Jul; 32(7):1506-11. PubMed ID: 5030579
    [No Abstract]   [Full Text] [Related]  

  • 19. The intracellular concentration dependence of antifolate inhibition of DNA synthesis in L1210 leukemia cells.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1974 Dec; 34(12):332-40. PubMed ID: 4429954
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of E. coli-L-asparaginase on the nucleic acid metabolism of lymphatic bovine leukemia cells].
    Seeber S; Warnecke P; Straub OC
    Arzneimittelforschung; 1969 Oct; 19(10):1745-8. PubMed ID: 4902492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.